LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lifecore Biomedical, Inc. \De\ quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q3 2024.
  • Lifecore Biomedical, Inc. \De\ Operating Lease, Right-of-Use Asset for the quarter ending August 25, 2024 was $2.37M, a 42.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.37M -$1.79M -42.9% Aug 25, 2024 10-Q 2024-10-04
Q2 2024 $2.44M -$1.84M -43% May 26, 2024 10-Q 2024-10-04
Q1 2024 $2.51M -$2.59M -50.8% Feb 25, 2024 10-Q 2024-08-09
Q4 2023 $4.04M -$1.22M -23.1% Nov 26, 2023 10-Q 2024-08-09
Q3 2023 $4.16M -$1.24M -22.9% Aug 27, 2023 10-Q 2024-08-09
Q2 2023 $4.28M -$1.27M -22.9% May 28, 2023 10-K 2024-08-26
Q1 2023 $5.1M -$603K -10.6% Feb 26, 2023 10-K 2024-03-20
Q4 2022 $5.25M -$2.24M -29.9% Nov 27, 2022 10-K 2024-03-20
Q3 2022 $5.4M -$2.3M -29.9% Aug 28, 2022 10-K 2024-03-20
Q2 2022 $5.55M -$7.98M -59% May 29, 2022 10-K 2024-03-20
Q1 2022 $5.7M -$9.7M -63% Feb 27, 2022 10-K 2024-03-20
Q4 2021 $7.49M -$5.2M -41% Nov 28, 2021 10-K 2024-03-20
Q3 2021 $7.7M -$5.66M -42.4% Aug 29, 2021 10-K 2024-03-20
Q2 2021 $13.5M -$11.8M -46.5% May 30, 2021 10-K 2024-03-20
Q1 2021 $15.4M -$9.78M -38.8% Feb 28, 2021 10-K 2024-03-20
Q4 2020 $12.7M -$17.1M -57.4% Nov 29, 2020 10-K 2024-03-20
Q3 2020 $13.4M -$15.4M -53.5% Aug 30, 2020 10-K 2024-03-20
Q2 2020 $25.3M +$25.3M May 31, 2020 10-K 2021-07-29
Q1 2020 $25.2M Feb 23, 2020 10-Q 2020-04-03
Q4 2019 $29.8M Nov 24, 2019 10-Q 2020-01-02
Q3 2019 $28.7M Aug 25, 2019 10-Q 2019-10-03
Q2 2019 $0 May 26, 2019 10-K 2020-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.